Compound_ID	Active	Smiles	canonical_smi	Set	Set_type	MW	HBD	HBA	NRB	NR	NAR	PSA	Standard Type	Standard Relation	Standard Units	Standard Value	Assay ChEMBL ID	Assay Description	BAO Label
CHEMBL4168002	1.0	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCOCC3)cc2)c2ccsc2n1	Cc1nc(Nc2c[nH]nc2C(=O)Nc2ccc(CN3CCOCC3)cc2)c2ccsc2n1		Test	449.54	3	7	6	5	4	108.06	IC50	'='	nM	3.63	CHEMBL4155885	Inhibition of human FLT3 by Hotspot assay	single protein format
CHEMBL4066684	1.0	Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1	Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1		Test	473.44	2	5	5	5	5	101.9	IC50	'='	nM	1.32	CHEMBL4034165	Inhibition of Flt-3 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	single protein format
CHEMBL255955	1.0	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		Test	412.38	4	4	3	4	4	108.72	IC50	'='	nM	2.0	CHEMBL930126	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL3684981	1.0	CC1CNCc2ccc(Nc3ncc4c5ccncc5n([C@H]5CC[C@H](C)CC5)c4n3)nc21	CC1CNCc2ccc(Nc3ncc4c5ccncc5n([C@H]5CC[C@H](C)CC5)c4n3)nc21		Test	427.56	2	6	3	6	4	80.55	IC50	'='	nM	1.8	CHEMBL3705970	Kinase Assay: The FLT3 inhibitory activity of the CDK4/6-FLT3 inhibitors was determined with a HTRF kinase assay. The FLT3 enzyme (GST-FLT3 fusion) was purchased from Carna Biosciences. An ULight-labeled synthetic peptide derived from human Janus kinase 1 (aa1015-1027, ULight-JAK1, PerkinElmer) was utilized as the phosphoacceptor substrate. The assay was conducted in a 384-well white OptiPlate (PerkinElmer). The 20 μL reaction mixture contained 50 nM ULight-JAK1, 116 μM ATP, 0.0385 ng/μL FLT3 and dilutions of test compounds in the kinase buffer (50 mM Hepes, pH 7.6, 1 mM EGTA, 10 mM MgCl2, 2 mM DTT, and 0.005% Tween 20). The reaction was allowed to proceed for 1 hour at room temperature and was stopped by adding 20 μL of 10 mM EDTA, 2 nM LANCE Eu-W1024 anti-phospho-tyrosine antibody in LANCE detection buffer (PerkinElmer). The plates were incubated at room temperature for 2 hours after addition of detection reagents and then read on an Envision multimode reader (PerkinElmer).	single protein format
CHEMBL3237448	1.0	c1cc2c3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n(C3CCCC3)c2nn1	c1cc2c3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n(C3CCCC3)c2nn1		Test	415.51	2	8	4	6	4	96.68	IC50	'='	nM	95.0	CHEMBL3240326	Inhibition of GST-fused human FLT3 cytoplasmic domain (amino acids 564 to 993) using Ulight-JAK1 as substrate after 1 hr by TR-FRET assay	single protein format
CHEMBL3237706	1.0	C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4ccc(N5CCNCC5)nc4)nc32)CC1	C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4ccc(N5CCNCC5)nc4)nc32)CC1		Test	442.57	2	7	4	6	4	83.79	IC50	'='	nM	0.3	CHEMBL3240326	Inhibition of GST-fused human FLT3 cytoplasmic domain (amino acids 564 to 993) using Ulight-JAK1 as substrate after 1 hr by TR-FRET assay	single protein format
CHEMBL3894634	1.0	CN(c1ccc(C(=O)Nc2n[nH]c3cc(OCCOCc4ccccc4)ccc23)cc1)C1CC[N+](C)([O-])CC1	CN(c1ccc(C(=O)Nc2n[nH]c3cc(OCCOCc4ccccc4)ccc23)cc1)C1CC[N+](C)([O-])CC1		Test	529.64	2	6	10	5	4	102.54	IC50	'='	nM	52.0	CHEMBL3888812	Biochemical Assay: The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activated with 800 microM ATP for 1 hour at 28° C in order to obtain a linear kinetic. Kinase buffer was composed of 50 mM HEPES pH 7.9 containing 4 mM MgCl2, 1 mM DTT, 10 microM Na3VO4, and 0.2 mg/mL BSA. The FLT3 kinase assay was run with a final pre activated enzyme concentration of 2 nM, in the presence of 254 microM ATP (residual ATP from KIT pre activation step is negligible), 8 nM 33P-γ-ATP and 55 microM of substrate BioDB n*24 (Aminoacidic sequence: GGKKKVSRSGLYRSPSMPENLNRPR- SEQ ID NO: 1).	single protein format
CHEMBL428380	1.0	CCO/N=C/c1c(N)ncnc1N1CCN(C(=O)Nc2ccc(N3CCCCC3)cc2)CC1	CCO/N=C/c1c(N)ncnc1N1CCN(C(=O)Nc2ccc(N3CCCCC3)cc2)CC1		Test	452.56	2	7	6	4	2	112.21	IC50	'='	nM	49.0	CHEMBL897762	Inhibition of human FLT3	single protein format
CHEMBL1095687	1.0	O=C1Nc2ccc(S(=O)(=O)[O-])cc2/C1=C1/Nc2ccccc2/C1=N\O	O=C1Nc2ccc(S(=O)(=O)[O-])cc2/C1=C1/Nc2ccccc2/C1=N\O		Test	356.34	3	6	1	4	2	130.92	IC50	'='	nM	9.0	CHEMBL1106056	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL520717	1.0	CCOc1nc(NCCc2ccncc2)ncc1-c1nnc(C2CC2)o1	CCOc1nc(NCCc2ccncc2)ncc1-c1nnc(C2CC2)o1		Test	352.4	1	8	8	4	3	98.85	IC50	'='	nM	80.0	CHEMBL939483	Inhibition of GST-tagged FLT3 by ELISA	single protein format
CHEMBL2063320	1.0	O=C(Nc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)Oc1ccccc1	O=C(Nc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)Oc1ccccc1		Test	511.58	3	6	9	5	4	108.58	IC50	'='	nM	40.0	CHEMBL2066303	Inhibition of wild type FLT3	single protein format
CHEMBL271600	1.0	Nc1noc2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12	Nc1noc2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		Test	378.82	3	4	3	4	4	93.18	IC50	'='	nM	6.0	CHEMBL949291	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL3780676	1.0	COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1	COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		Test	740.21	1	8	11	7	6	98.16	IC50	'='	nM	2.15	CHEMBL3782290	Inhibition of FLT3 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	single protein format
CHEMBL219998	1.0	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c(N)n[nH]c12	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C)c3)cc2)c2c(N)n[nH]c12		Test	387.44	4	4	4	4	4	105.06	IC50	'='	nM	29.0	CHEMBL920440	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL210833	1.0	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		Test	360.44	2	4	5	3	2	90.65	IC50	'='	nM	42.0	CHEMBL868169	Inhibition of FLT3	single protein format
CHEMBL3612498	1.0	Cc1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Cl)nc12	Cc1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Cl)nc12		Test	388.84	0	5	4	3	3	103.72	IC50	'='	nM	33.0	CHEMBL3615646	Inhibition of FLT3 (unknown origin) using biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 as substrate after 90 mins by luminescence assay	single protein format
CHEMBL374330	1.0	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)cc1	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)cc1		Test	357.42	4	3	3	4	4	95.83	IC50	'='	nM	2.0	CHEMBL920440	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL4240512	1.0	C/C=C\C(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)cc1C	C/C=C\C(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)cc1C		Test	456.51	4	6	5	4	4	135.17	IC50	'='	nM	39.0	CHEMBL4236210	Inhibition of human FLT3 using biotin labeled substrate after 1 hr by HTFR assay	single protein format
CHEMBL4572972	1.0	CCn1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)c2c(N)ncnc21	CCn1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)c2c(N)ncnc21		Test	419.49	3	6	4	4	4	123.89	IC50	'='	nM	7.0	CHEMBL4385972	Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	single protein format
CHEMBL410504	1.0	Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12	Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		Test	362.36	3	4	3	4	4	93.18	IC50	'='	nM	8.0	CHEMBL949291	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL4579738	1.0	O=C1Nc2ccccc2C1=Cc1ccc2c(-c3cccnc3)n[nH]c2c1	O=C1Nc2ccccc2C1=Cc1ccc2c(-c3cccnc3)n[nH]c2c1		Test	338.37	2	3	2	5	4	70.67	IC50	'='	nM	27.0	CHEMBL4430365	Inhibition of FLT3 (unknown origin)	single protein format
CHEMBL4517711	1.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3c[nH]c4ncnc(N)c34)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3c[nH]c4ncnc(N)c34)cc2)no1		Test	391.44	4	6	3	4	4	134.75	IC50	'='	nM	6.0	CHEMBL4385972	Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	single protein format
CHEMBL3687220	1.0	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1		Test	522.7	3	9	8	5	2	111.88	IC50	'='	nM	0.51	CHEMBL3706339	Inhibition Assay: A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Example 5. Test Example 5: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 ÂµM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.	single protein format
CHEMBL3687222	1.0	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1		Test	457.55	3	8	7	4	2	108.64	IC50	'='	nM	0.36	CHEMBL3706339	Inhibition Assay: A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Example 5. Test Example 5: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 ÂµM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.	single protein format
CHEMBL2032285	1.0	Nc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1	Nc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1		Test	375.44	3	7	3	5	4	120.81	IC50	'='	nM	3.6	CHEMBL2034188	Inhibition of recombinant FLT3 by time resolved-fluorescence resonance energy transfer analysis	single protein format
CHEMBL4247248	1.0	Cc1cc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c2c(N)onc2n1	Cc1cc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c2c(N)onc2n1		Test	461.83	3	5	3	4	4	106.07	IC50	'='	nM	3.0	CHEMBL4236210	Inhibition of human FLT3 using biotin labeled substrate after 1 hr by HTFR assay	single protein format
CHEMBL3970921	1.0	Cc1ccc2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1	Cc1ccc2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		Test	429.52	3	5	4	5	4	100.18	IC50	'='	nM	0.77	CHEMBL3887269	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	single protein format
CHEMBL1258150	1.0	Cc1cc(/C=C2\C(=O)Nc3ccc(F)cc32)c2ccccc(OCCCN(C)C)c1-2	Cc1cc(/C=C2\C(=O)Nc3ccc(F)cc32)c2ccccc(OCCCN(C)C)c1-2		Test	404.49	1	3	6	4	3	41.57	IC50	'='	nM	12.0	CHEMBL1261358	Inhibition of FLT3 by time resolved fluorescence method	single protein format
CHEMBL1915445	1.0	Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1	Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1		Test	388.82	3	6	3	5	5	99.61	IC50	'='	nM	39.0	CHEMBL1919426	Inhibition of FLT3 using EAIYAAPFAKKK as substrate by radiometric assay in the presence of 200 uM [ATP]	single protein format
CHEMBL262607	1.0	Cc1ccc(F)c(NC(=O)Nc2ccc(C3=Nc4c(N)ncnc4NCC3)cc2)c1	Cc1ccc(F)c(NC(=O)Nc2ccc(C3=Nc4c(N)ncnc4NCC3)cc2)c1		Test	405.44	4	5	3	4	3	117.32	IC50	'='	nM	13.0	CHEMBL928169	Inhibition of Flt3	single protein format
CHEMBL3687223	1.0	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1		Test	483.62	3	9	8	4	2	117.87	IC50	'='	nM	0.49	CHEMBL3706339	Inhibition Assay: A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Example 5. Test Example 5: A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a peptide substrate was investigated using an EZ reader (Caliper). Test compounds were each mixed with a protein solution to give 8 final concentrations from 100 nM to 0.03 nM, followed by addition of a mixed liquid of ATP and substrate peptide (Caliper) and reaction for 30 minutes. The ATP concentration used was 100 ÂµM. A reaction liquid which contained protein but no test compound (in which the solvent DMSO alone was added at 0.8% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.	single protein format
CHEMBL3353355	1.0	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5CCOCC5)cc4)n[nH]c3c1)C(=O)N2	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5CCOCC5)cc4)n[nH]c3c1)C(=O)N2		Test	506.61	2	5	6	7	4	79.48	IC50	'='	nM	65.0	CHEMBL3364611	Inhibition of FLT3 (unknown origin) by FRET-based homogeneous assay	single protein format
CHEMBL3329673	1.0	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c(F)c1	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c(F)c1		Test	520.52	5	6	7	4	3	149.62	IC50	'='	nM	10.0	CHEMBL3380434	Inhibition of FLT3 (unknown origin) using EAIYAAPFAKKK substrate	single protein format
CHEMBL3680380	1.0	CC(=O)N1CCc2nc(Nc3ncc4c5ccncc5n([C@H]5CC[C@H](C)CC5)c4n3)ccc2C1	CC(=O)N1CCc2nc(Nc3ncc4c5ccncc5n([C@H]5CC[C@H](C)CC5)c4n3)ccc2C1		Test	455.57	1	6	3	6	4	88.83	IC50	'='	nM	3.2	CHEMBL3705970	Kinase Assay: The FLT3 inhibitory activity of the CDK4/6-FLT3 inhibitors was determined with a HTRF kinase assay. The FLT3 enzyme (GST-FLT3 fusion) was purchased from Carna Biosciences. An ULight-labeled synthetic peptide derived from human Janus kinase 1 (aa1015-1027, ULight-JAK1, PerkinElmer) was utilized as the phosphoacceptor substrate. The assay was conducted in a 384-well white OptiPlate (PerkinElmer). The 20 μL reaction mixture contained 50 nM ULight-JAK1, 116 μM ATP, 0.0385 ng/μL FLT3 and dilutions of test compounds in the kinase buffer (50 mM Hepes, pH 7.6, 1 mM EGTA, 10 mM MgCl2, 2 mM DTT, and 0.005% Tween 20). The reaction was allowed to proceed for 1 hour at room temperature and was stopped by adding 20 μL of 10 mM EDTA, 2 nM LANCE Eu-W1024 anti-phospho-tyrosine antibody in LANCE detection buffer (PerkinElmer). The plates were incubated at room temperature for 2 hours after addition of detection reagents and then read on an Envision multimode reader (PerkinElmer).	single protein format
CHEMBL4571608	1.0	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc5ccccc5s4)n[nH]3)cc2)CC1	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc5ccccc5s4)n[nH]3)cc2)CC1		Test	431.57	3	4	5	5	4	73.05	IC50	'='	nM	10.51	CHEMBL4353138	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate in presence of 33P-gamma ATP by hotspot kinase assay	single protein format
CHEMBL2046726	1.0	COc1cc2ncnc(Sc3nncs3)c2cc1OC	COc1cc2ncnc(Sc3nncs3)c2cc1OC		Test	306.37	0	7	4	3	3	70.02	IC50	'='	nM	9.0	CHEMBL2050053	Inhibition of human FLT3	single protein format
CHEMBL3353347	1.0	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)cc1	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)cc1		Test	434.54	2	3	5	6	4	61.02	IC50	'='	nM	11.0	CHEMBL3364611	Inhibition of FLT3 (unknown origin) by FRET-based homogeneous assay	single protein format
CHEMBL1915641	1.0	Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12	Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		Test	469.52	2	7	7	6	5	91.85	IC50	'='	nM	61.0	CHEMBL1919426	Inhibition of FLT3 using EAIYAAPFAKKK as substrate by radiometric assay in the presence of 200 uM [ATP]	single protein format
CHEMBL3684979	1.0	C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4cc5c(cn4)CCNC5)nc32)CC1	C[C@H]1CC[C@H](n2c3cnccc3c3cnc(Nc4cc5c(cn4)CCNC5)nc32)CC1		Test	413.53	2	6	3	6	4	80.55	IC50	'='	nM	73.7	CHEMBL3705970	Kinase Assay: The FLT3 inhibitory activity of the CDK4/6-FLT3 inhibitors was determined with a HTRF kinase assay. The FLT3 enzyme (GST-FLT3 fusion) was purchased from Carna Biosciences. An ULight-labeled synthetic peptide derived from human Janus kinase 1 (aa1015-1027, ULight-JAK1, PerkinElmer) was utilized as the phosphoacceptor substrate. The assay was conducted in a 384-well white OptiPlate (PerkinElmer). The 20 μL reaction mixture contained 50 nM ULight-JAK1, 116 μM ATP, 0.0385 ng/μL FLT3 and dilutions of test compounds in the kinase buffer (50 mM Hepes, pH 7.6, 1 mM EGTA, 10 mM MgCl2, 2 mM DTT, and 0.005% Tween 20). The reaction was allowed to proceed for 1 hour at room temperature and was stopped by adding 20 μL of 10 mM EDTA, 2 nM LANCE Eu-W1024 anti-phospho-tyrosine antibody in LANCE detection buffer (PerkinElmer). The plates were incubated at room temperature for 2 hours after addition of detection reagents and then read on an Envision multimode reader (PerkinElmer).	single protein format
CHEMBL222315	1.0	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4CCCCC4)cc3)c12	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4CCCCC4)cc3)c12		Test	334.42	3	3	3	4	3	83.8	IC50	'='	nM	13.0	CHEMBL920440	Inhibition of FLT3 by HTRF assay	single protein format
CHEMBL3329668	1.0	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1		Test	488.5	5	6	6	4	3	149.62	IC50	'='	nM	31.7	CHEMBL3380434	Inhibition of FLT3 (unknown origin) using EAIYAAPFAKKK substrate	single protein format
CHEMBL1969102	1.0	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		Test	440.53	4	4	4	5	5	108.72	IC50	'='	nM	1.81	CHEMBL3707703	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 μM N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 μL final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	single protein format
CHEMBL3959866	1.0	CC1(C)CN(c2ccc(-c3oc(-c4ccc(Cl)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1	CC1(C)CN(c2ccc(-c3oc(-c4ccc(Cl)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		Test	449.94	3	5	4	5	4	100.18	IC50	'='	nM	0.97	CHEMBL3887269	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	single protein format
CHEMBL3237705	1.0	CC1(C)CCCC(n2c3cnccc3c3cnc(Nc4ccc(N5CCNCC5)cn4)nc32)C1	CC1(C)CCCC(n2c3cnccc3c3cnc(Nc4ccc(N5CCNCC5)cn4)nc32)C1		Test	456.6	2	7	4	6	4	83.79	IC50	'='	nM	3.0	CHEMBL3240326	Inhibition of GST-fused human FLT3 cytoplasmic domain (amino acids 564 to 993) using Ulight-JAK1 as substrate after 1 hr by TR-FRET assay	single protein format
CHEMBL4437322	1.0	COc1ccc(-c2cc(NC(=O)c3ccc(NC4CCN(C)CC4)cc3)[nH]n2)cc1OC	COc1ccc(-c2cc(NC(=O)c3ccc(NC4CCN(C)CC4)cc3)[nH]n2)cc1OC		Test	435.53	3	6	7	4	3	91.51	IC50	'='	nM	63.65	CHEMBL4353138	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate in presence of 33P-gamma ATP by hotspot kinase assay	single protein format
CHEMBL1940275	1.0	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		Test	446.51	2	7	8	4	4	103.19	IC50	'='	nM	20.0	CHEMBL2026428	Inhibition of Flt3	single protein format
CHEMBL3646211	1.0	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1		Test	530.61	5	7	8	5	5	147.55	IC50	'='	nM	1.22	CHEMBL3707703	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 μM N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 μL final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	single protein format
CHEMBL4870241	1.0	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]nc(Cl)c3c2c2c1CCCCC2	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]nc(Cl)c3c2c2c1CCCCC2		Test	405.81	2	3	1	5	4	70.25	IC50	'='	nM	34.0	CHEMBL4836766	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method	single protein format
CHEMBL3612504	1.0	COc1ccc(-c2ccn3ncc(/C=N/N(C)S(=O)(=O)c4cc([N+](=O)[O-])ccc4C)c3n2)cc1OC	COc1ccc(-c2ccn3ncc(/C=N/N(C)S(=O)(=O)c4cc([N+](=O)[O-])ccc4C)c3n2)cc1OC		Test	510.53	0	8	8	4	4	141.53	IC50	'='	nM	3.12	CHEMBL3615646	Inhibition of FLT3 (unknown origin) using biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 as substrate after 90 mins by luminescence assay	single protein format
CHEMBL4865741	1.0	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]ncc3c2c2c1CC(N1CCOCC1)CC2	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]ncc3c2c2c1CC(N1CCOCC1)CC2		Test	442.45	2	5	2	6	4	82.72	IC50	'='	nM	16.0	CHEMBL4836766	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method	single protein format
CHEMBL4093755	1.0	Cc1sc2ncnc(Nc3c[nH]nc3C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2c1C	Cc1sc2ncnc(Nc3c[nH]nc3C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2c1C		Test	476.61	3	7	6	5	4	102.07	IC50	'='	nM	0.576	CHEMBL4059187	Inhibition of human FLT3 using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measure after 120 mins by filter binding method	single protein format
CHEMBL4099013	1.0	CC(C)c1cc2c(Nc3c[nH]nc3C(=O)Nc3ccc(CN4CCOCC4)cc3)ncnc2s1	CC(C)c1cc2c(Nc3c[nH]nc3C(=O)Nc3ccc(CN4CCOCC4)cc3)ncnc2s1		Test	477.59	3	7	7	5	4	108.06	IC50	'='	nM	7.63	CHEMBL4059187	Inhibition of human FLT3 using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measure after 120 mins by filter binding method	single protein format
CHEMBL4216680	1.0	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCC[C@@H]2C(=O)O)CC1	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCC[C@@H]2C(=O)O)CC1		Test	497.6	2	7	6	6	4	106.5	IC50	'='	nM	16.0	CHEMBL4180099	Inhibition of recombinant human C-terminal FLT3 ITD mutant (571 to 993 residues) after 90 mins by mobility shift assay	single protein format
CHEMBL4861566	1.0	CC(=O)NC1CCc2c(c(-c3c[nH]nc3C(F)(F)F)nc3ccc4[nH]ncc4c23)C1	CC(=O)NC1CCc2c(c(-c3c[nH]nc3C(F)(F)F)nc3ccc4[nH]ncc4c23)C1		Test	414.39	3	4	2	5	4	99.35	IC50	'='	nM	20.0	CHEMBL4836766	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method	single protein format
CHEMBL4461271	1.0	CN1CCN(c2ccc(Nc3cc(-c4ccc(Cl)s4)n[nH]3)cc2)CC1	CN1CCN(c2ccc(Nc3cc(-c4ccc(Cl)s4)n[nH]3)cc2)CC1		Test	373.91	2	4	4	4	3	47.19	IC50	'='	nM	1.503	CHEMBL4353138	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate in presence of 33P-gamma ATP by hotspot kinase assay	single protein format
CHEMBL4077278	1.0	O=C(Nc1ccc(CN2CCOCC2)cc1)c1n[nH]cc1Nc1ncnc2ccsc12	O=C(Nc1ccc(CN2CCOCC2)cc1)c1n[nH]cc1Nc1ncnc2ccsc12		Test	435.51	3	7	6	5	4	108.06	IC50	'='	nM	6.15	CHEMBL4059187	Inhibition of human FLT3 using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measure after 120 mins by filter binding method	single protein format
CHEMBL4533224	1.0	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		Test	405.46	2	6	4	5	3	82.72	IC50	'='	nM	4.434	CHEMBL4353138	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate in presence of 33P-gamma ATP by hotspot kinase assay	single protein format
CHEMBL4860567	1.0	Cc1n[nH]c2ccc3nc(-c4c[nH]nc4C(F)(F)F)c4c(c3c12)CCC(C#N)C4	Cc1n[nH]c2ccc3nc(-c4c[nH]nc4C(F)(F)F)c4c(c3c12)CCC(C#N)C4		Test	396.38	2	4	1	5	4	94.04	IC50	'='	nM	15.0	CHEMBL4836766	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs by filter binding method	single protein format
CHEMBL1995703	1.0	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		Test	509.68	3	8	7	4	3	102.49	IC50	'='	nM	25.0	CHEMBL3877190	Inhibition of FLT3 (unknown origin)	single protein format
CHEMBL1835749	1.0	Nc1nc(Nc2ccc(C(=O)NCCN3CCOCC3)cc2)nn1-c1ccccn1	Nc1nc(Nc2ccc(C(=O)NCCN3CCOCC3)cc2)nn1-c1ccccn1		Test	408.47	3	8	7	4	3	123.22	IC50	'='	nM	19.0	CHEMBL1958984	Inhibition of human recombinant FLT3 by radiometric assay	single protein format
CHEMBL1980297	1.0	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		Test	488.55	4	5	6	5	5	118.09	IC50	'='	nM	1.21	CHEMBL3707703	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 μM N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 μL final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	single protein format
CHEMBL3416147	1.0	N#CCc1ccc(-c2cnc3cc(-c4cccs4)ccn23)cc1	N#CCc1ccc(-c2cnc3cc(-c4cccs4)ccn23)cc1		Test	315.4	0	2	3	4	4	41.09	IC50	'='	nM	51.0	CHEMBL3420606	Inhibition of FLT3 (unknown origin) using FAM-EPLYWSFPA as substrate preincubated for 60 mins followed by substrate addition by microfluidics assay in presence of 190 uM ATP	single protein format
CHEMBL5087138	1.0	O=C(Nc1ccc(N2CCOCC2)cc1C(F)(F)F)c1cnn2ccc(N[C@@H]3CCCNC3)nc12	O=C(Nc1ccc(N2CCOCC2)cc1C(F)(F)F)c1cnn2ccc(N[C@@H]3CCCNC3)nc12		Test	489.5	3	7	5	5	3	95.82	IC50	'='	nM	0.57	CHEMBL5054520	Inhibition of FLT3-ITD mutant (unknown origin) using Poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA	single protein format
CHEMBL2203775	1.0	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(N6CCN(C)CC6)c5)nc34)CC2)no1	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(N6CCN(C)CC6)c5)nc34)CC2)no1		Test	507.04	1	8	5	6	4	80.56	Kd	'='	nM	5.4	CHEMBL2214092	Binding affinity to FLT3	single protein format
CHEMBL1765774	1.0	CNc1cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)ccn1	CNc1cc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCCCC4)cc3)c2)ccn1		Test	403.49	3	5	5	4	3	90.12	Ki	'='	nM	6.0	CHEMBL1768450	Inhibition of Flt3 after 20 mins by radiometric phosphate incorporation assay	single protein format
CHEMBL4167646	1.0	COc1ccc(Nc2nccc(-c3sc(SCCN(C)C)nc3C)n2)c(OC)c1	COc1ccc(Nc2nccc(-c3sc(SCCN(C)C)nc3C)n2)c(OC)c1		Test	431.59	1	8	9	3	3	72.4	Ki	'='	nM	7.0	CHEMBL4133273	Inhibition of recombinant human FLT3 using EAIYAAPFAKKK as substrate by ATP-Glo assay	single protein format
CHEMBL1835744	1.0	N#Cc1ccc(-n2nc(Nc3ccccc3Cl)nc2N)nc1	N#Cc1ccc(-n2nc(Nc3ccccc3Cl)nc2N)nc1		Test	311.74	2	6	3	3	3	105.44	Ki	'='	nM	15.0	CHEMBL1840408	Displacement of [33P]ATP from human recombinant FLT3 domain after 20 mins by scintillation counting	single protein format
CHEMBL1835741	1.0	COc1ccccc1Nc1nc(N)n(-c2ccccn2)n1	COc1ccccc1Nc1nc(N)n(-c2ccccn2)n1		Test	282.31	2	6	4	3	3	90.88	Ki	'='	nM	15.0	CHEMBL1840408	Displacement of [33P]ATP from human recombinant FLT3 domain after 20 mins by scintillation counting	single protein format
CHEMBL1079545	1.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1		Test	395.42	4	6	4	3	3	129.38	Kd	'='	nM	0.74	CHEMBL1112284	Binding affinity to FLT3	single protein format
CHEMBL1081509	1.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1		Test	429.48	3	5	4	4	4	109.15	Kd	'='	nM	1.1	CHEMBL1112284	Binding affinity to FLT3	single protein format
CHEMBL1081510	1.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3ccccc3)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(C(=O)Nc3ccccc3)cc2)no1		Test	378.43	3	4	4	3	3	96.26	Kd	'='	nM	7.4	CHEMBL1112284	Binding affinity to FLT3	single protein format
CHEMBL1079544	1.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cccc(O)n3)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cccc(O)n3)cc2)no1		Test	395.42	4	6	4	3	3	129.38	Kd	'='	nM	2.5	CHEMBL1112284	Binding affinity to FLT3	single protein format
CHEMBL4866028	1.0	CC(=O)N1CCN(c2ccc(Nc3ncc(C#N)c(-c4cn(C)c5ccccc45)n3)cc2)CC1	CC(=O)N1CCN(c2ccc(Nc3ncc(C#N)c(-c4cn(C)c5ccccc45)n3)cc2)CC1		Test	451.53	1	6	4	5	4	90.08	Ki	'='	nM	22.0	CHEMBL4815226	Inhibition of wild type FLT3 (unknown origin) using Glu/Tyr peptide substrate incubated for 120 mins measured after 40 mins incubation under dark by ADP-glo based luminescence assay	single protein format
CHEMBL4878159	1.0	CC(=O)N1CCN(c2ccc(Nc3ncc(C#N)c(-c4n[nH]c5ccccc45)n3)cc2)CC1	CC(=O)N1CCN(c2ccc(Nc3ncc(C#N)c(-c4n[nH]c5ccccc45)n3)cc2)CC1		Test	438.5	2	7	4	5	4	113.83	Ki	'='	nM	10.6	CHEMBL4815227	Inhibition of FLT3 ITD mutant (unknown origin) using Glu/Tyr peptide substrate incubated for 120 mins measured after 40 mins incubation under dark by ADP-glo based luminescence assay	single protein format
CHEMBL4455084	0.0	Fc1ccc(/C=C/c2nc(N3CCC[C@H]3CN3CCCC3)c3cc(Cl)ccc3n2)cc1F	Fc1ccc(/C=C/c2nc(N3CCC[C@H]3CN3CCCC3)c3cc(Cl)ccc3n2)cc1F		Test	454.95	0	4	5	5	3	32.26	IC50	'='	nM	12500.0	CHEMBL4315097	Inhibition of FLT3 ITD mutant (unknown origin) using TAMRA-Src-tide as substrate measured after 1 hr in presence of ATP at its Km concentration by IMAP-FP assay	single protein format
CHEMBL4068876	0.0	CSc1nc(Nc2cccc(Cl)c2)c2ccn(CC(Cl)c3ccccc3)c2n1	CSc1nc(Nc2cccc(Cl)c2)c2ccn(CC(Cl)c3ccccc3)c2n1		Test	429.38	1	4	6	4	4	42.74	IC50	'='	nM	55000.0	CHEMBL3993693	Inhibition of Flt3 (unknown origin) using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL453336	0.0	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		Test	484.55	1	5	9	5	4	70.95	IC50	'='	nM	36000.0	CHEMBL957979	Inhibition of human recombinant FLT3	single protein format
CHEMBL488646	0.0	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		Test	450.54	1	5	7	4	3	70.95	IC50	'='	nM	20000.0	CHEMBL957979	Inhibition of human recombinant FLT3	single protein format
CHEMBL4869181	0.0	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3F)cc2)o1	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3F)cc2)o1		Test	399.43	0	5	5	5	5	59.46	IC50	'='	nM	50118.72	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4852533	0.0	Cc1cc(-c2c(C)n[nH]c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1	Cc1cc(-c2c(C)n[nH]c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		Test	413.49	1	6	5	5	5	88.14	IC50	'='	nM	39810.72	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4850040	0.0	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3)cc2)o1	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3)cc2)o1		Test	381.44	0	5	5	5	5	59.46	IC50	'='	nM	25118.86	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL106966	0.0	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		Test	418.46	1	7	4	4	3	103.61	IC50	'='	nM	19700.0	CHEMBL679498	Inhibition of Flt3 kinase	single protein format
CHEMBL4088440	0.0	CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1	CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1		Test	342.44	0	4	4	4	3	33.95	IC50	'='	nM	64000.0	CHEMBL3993693	Inhibition of Flt3 (unknown origin) using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL486437	0.0	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		Test	494.66	1	5	10	4	3	70.95	IC50	'='	nM	34000.0	CHEMBL957979	Inhibition of human recombinant FLT3	single protein format
CHEMBL4865752	0.0	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(Cl)c1	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(Cl)c1		Test	447.93	0	6	5	5	5	77.28	IC50	'='	nM	19952.62	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4541332	0.0	COc1cc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc(OC)c1OC	COc1cc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc(OC)c1OC		Test	422.53	1	7	10	3	3	68.74	IC50	'='	nM	12500.0	CHEMBL4315097	Inhibition of FLT3 ITD mutant (unknown origin) using TAMRA-Src-tide as substrate measured after 1 hr in presence of ATP at its Km concentration by IMAP-FP assay	single protein format
CHEMBL4877985	0.0	Cc1cc(-c2c(C)nn(C(F)F)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1	Cc1cc(-c2c(C)nn(C(F)F)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		Test	463.49	0	6	6	5	5	77.28	IC50	'='	nM	100000.0	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4799967	0.0	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(OC3CCCC3)cc2)o1	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(OC3CCCC3)cc2)o1		Test	389.46	0	6	6	5	4	68.69	IC50	'='	nM	19952.62	CHEMBL4739200	Inhibition of His6/TEV fused-GST-tagged Flt3 (unknown origin) (H564 to S993 residues) using Axltide (CKKSRGDYMTMQJ-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 75 mins by RapidFire LC-MS analysis	single protein format
CHEMBL4859554	0.0	COc1ccccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1	COc1ccccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		Test	411.47	0	6	6	5	5	68.69	IC50	'='	nM	50118.72	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4463686	0.0	CCN(CC)CCCC(C)Nc1nc(/C=C/c2ccc(F)c(F)c2)nc2ccc(Cl)cc12	CCN(CC)CCCC(C)Nc1nc(/C=C/c2ccc(F)c(F)c2)nc2ccc(Cl)cc12		Test	458.98	1	4	10	3	3	41.05	IC50	'='	nM	10450.0	CHEMBL4315097	Inhibition of FLT3 ITD mutant (unknown origin) using TAMRA-Src-tide as substrate measured after 1 hr in presence of ATP at its Km concentration by IMAP-FP assay	single protein format
CHEMBL4100526	0.0	CSc1nc(N2CCOCC2)c2ccn(Cc3ccc(F)cc3)c2n1	CSc1nc(N2CCOCC2)c2ccn(Cc3ccc(F)cc3)c2n1		Test	358.44	0	5	4	4	3	43.18	IC50	'='	nM	61000.0	CHEMBL3993693	Inhibition of Flt3 (unknown origin) using KVEKIGEGTYGVVYK as substrate after 10 mins in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL4755626	0.0	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3Cl)nc2)o1	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3Cl)nc2)o1		Test	416.87	0	6	5	5	5	72.35	IC50	'='	nM	15848.93	CHEMBL4739200	Inhibition of His6/TEV fused-GST-tagged Flt3 (unknown origin) (H564 to S993 residues) using Axltide (CKKSRGDYMTMQJ-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 75 mins by RapidFire LC-MS analysis	single protein format
CHEMBL4870528	0.0	Cc1cc(-c2c(C#N)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1	Cc1cc(-c2c(C#N)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		Test	438.5	0	7	5	5	5	101.07	IC50	'='	nM	25118.86	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4851329	0.0	Cc1ncccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1	Cc1ncccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		Test	396.45	0	6	5	5	5	72.35	IC50	'='	nM	19952.62	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4872116	0.0	COc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1	COc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		Test	443.51	0	7	6	5	5	86.51	IC50	'='	nM	39810.72	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4869862	0.0	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3C#N)cc2)o1	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3C#N)cc2)o1		Test	406.45	0	6	5	5	5	83.25	IC50	'='	nM	10000.0	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4875486	0.0	Cc1cc(-c2c(C)nn(C)c2C#N)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1	Cc1cc(-c2c(C)nn(C)c2C#N)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		Test	438.5	0	7	5	5	5	101.07	IC50	'='	nM	15848.93	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL4877912	0.0	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(C#N)c1	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(C#N)c1		Test	438.5	0	7	5	5	5	101.07	IC50	'='	nM	79432.82	CHEMBL4828159	Inhibition of FLT3 (unknown origin) by LC-MS analysis	single protein format
CHEMBL1421	0.0	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		Test	488.02	3	8	7	4	3	106.51	IC50	'='	nM	25700.0	CHEMBL4807615	Inhibition of FLT3 (unknown origin) using poly(Ala, Glu, Lys, Tyr) as substrate	single protein format
CHEMBL4171176	0.0	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1		Test	448.96	2	6	5	5	4	77.15	Inhibition	'='	%	7.0	CHEMBL4153880	Inhibition of FLT3 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	single protein format
CHEMBL1173668	0.0	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)/C(=C\c1ccccc1)C(=O)N2	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)/C(=C\c1ccccc1)C(=O)N2		Test	389.84	3	2	3	4	3	70.23	Inhibition	'='	%	0.0	CHEMBL1176713	Inhibition of FLT3 at 0.1 uM	single protein format
CHEMBL4743414	0.0	COc1ccc2nc(NC(=O)Cc3ccc(NC(=O)Nc4cc(C)on4)cc3)sc2c1	COc1ccc2nc(NC(=O)Cc3ccc(NC(=O)Nc4cc(C)on4)cc3)sc2c1		Test	437.48	3	6	6	4	4	118.38	Inhibition	'='	%	-2.0	CHEMBL4670661	Inhibition of FLT3 ITD mutant (unknown origin) at 500 nM relative to control	single protein format
CHEMBL3593322	0.0	Cc1cccn2cc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc12	Cc1cccn2cc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc12		Test	389.46	2	4	3	4	4	84.46	Inhibition	'='	%	13.6	CHEMBL3594757	Inhibition of human FLT3 at 100 nM incubated for 40 mins using EAIYAAPFAKKK substrate and [gamma-33P-ATP] by scintillation counting method	single protein format
CHEMBL4436746	0.0	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		Test	631.96	2	4	6	5	5	81.07	Inhibition	'='	%	-2.82	CHEMBL4309589	Inhibition of human FLT3 at 10 uM using EAIYAAPFAKKK as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	single protein format
CHEMBL3264108	0.0	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		Test	425.47	1	6	10	3	3	73.34	Inhibition	'='	%	6.0	CHEMBL3267567	Inhibition of FLT3 (unknown origin) at 1 uM	single protein format
CHEMBL3593659	0.0	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4cccc(C(F)(F)F)c4n3)cc2)no1	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4cccc(C(F)(F)F)c4n3)cc2)no1		Test	443.43	2	4	3	4	4	84.46	Inhibition	'='	%	2.5	CHEMBL3594757	Inhibition of human FLT3 at 100 nM incubated for 40 mins using EAIYAAPFAKKK substrate and [gamma-33P-ATP] by scintillation counting method	single protein format
CHEMBL3330976	0.0	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccncc2)cc1	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccncc2)cc1		Test	414.42	3	5	4	4	3	109.42	Inhibition	'='	%	4.0	CHEMBL3380440	Inhibition of FLT3 (unknown origin) using EAIYAAPFAKKK substrate at 1 uM	single protein format
CHEMBL4798867	0.0	COc1ccc2nc(NC(=O)Cc3ccc(NC(=O)Nc4cc(C(C)(C)C)no4)cc3)sc2c1	COc1ccc2nc(NC(=O)Cc3ccc(NC(=O)Nc4cc(C(C)(C)C)no4)cc3)sc2c1		Test	479.56	3	6	6	4	4	118.38	Inhibition	'='	%	6.4	CHEMBL4670661	Inhibition of FLT3 ITD mutant (unknown origin) at 500 nM relative to control	single protein format
CHEMBL3747699	0.0	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		Test	465.48	1	7	5	4	3	106.42	Inhibition	'='	%	0.0	CHEMBL3750649	Inhibition of FLT3 (unknown origin) at 10 uM	single protein format
CHEMBL3746959	0.0	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		Test	479.49	2	7	5	5	4	92.51	Inhibition	'='	%	11.0	CHEMBL3750649	Inhibition of FLT3 (unknown origin) at 10 uM	single protein format
CHEMBL3797345	0.0	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2F)ccn1		Test	529.5	2	6	8	4	4	97.2	Inhibition	'='	%	17.6	CHEMBL3801448	Inhibition of FLT3 (unknown origin) at 10 uM after 1 hr by mobility shift assay	single protein format
CHEMBL3745734	0.0	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		Test	478.5	1	7	5	5	4	75.52	Inhibition	'='	%	6.0	CHEMBL3750649	Inhibition of FLT3 (unknown origin) at 10 uM	single protein format
CHEMBL3319470	0.0	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		Test	375.43	2	5	5	4	4	82.39	Inhibition	'='	%	18.0	CHEMBL3368341	Inhibition of FLT3 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	single protein format
CHEMBL3319468	0.0	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		Test	420.47	1	6	7	4	4	74.83	Inhibition	'='	%	1.6	CHEMBL3368341	Inhibition of FLT3 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	single protein format
CHEMBL4461102	0.0	CN1CCN(C(=O)c2ccc(Nc3nnc(-c4cc(C#N)cs4)o3)cc2)CC1	CN1CCN(C(=O)c2ccc(Nc3nnc(-c4cc(C#N)cs4)o3)cc2)CC1		Test	394.46	1	7	4	4	3	98.29	Inhibition	'='	%	-0.36	CHEMBL4353200	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate at 1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	single protein format
CHEMBL3330968	0.0	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)c(Cl)c2)cc1	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)c(Cl)c2)cc1		Test	482.32	3	4	4	4	3	96.53	Inhibition	'='	%	19.0	CHEMBL3380440	Inhibition of FLT3 (unknown origin) using EAIYAAPFAKKK substrate at 1 uM	single protein format
CHEMBL4451403	0.0	COc1ccc(Cc2c(-c3ccc(Cl)s3)n[nH]c2Nc2ccc(N3CCN(C)CC3)cc2)cc1	COc1ccc(Cc2c(-c3ccc(Cl)s3)n[nH]c2Nc2ccc(N3CCN(C)CC3)cc2)cc1		Test	494.06	2	5	7	5	4	56.42	Inhibition	'='	%	12.24	CHEMBL4353201	Inhibition of human FLT3 ITD mutant using EAIYAAPFAKKK peptide as substrate at 5 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	single protein format
CHEMBL103098	0.0	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		Test	356.41	3	4	4	4	3	117.94	Inhibition	'='	%	3.07	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1096626	0.0	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		Test	447.5	3	9	6	4	4	151.13	Inhibition	'='	%	-0.24	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL13868	0.0	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		Test	507.57	1	6	7	6	5	74.09	Inhibition	'='	%	-0.1	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL14014	0.0	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		Test	433.46	1	5	5	5	4	64.86	Inhibition	'='	%	3.64	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1785002	0.0	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		Test	472.52	2	6	7	5	4	107.95	Inhibition	'='	%	-0.57	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1794066	0.0	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21		Test	411.47	3	9	4	4	3	137.14	Inhibition	'='	%	2.2	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL186213	0.0	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		Test	462.44	1	6	5	5	5	77.23	Inhibition	'='	%	-1.77	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL188247	0.0	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		Test	504.47	1	7	4	6	5	86.46	Inhibition	'='	%	-0.9	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL188257	0.0	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		Test	452.47	1	8	5	6	5	95.69	Inhibition	'='	%	-2.36	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL188784	0.0	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		Test	468.39	1	5	4	5	5	68.0	Inhibition	'='	%	0.95	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL188794	0.0	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		Test	496.88	1	6	5	5	5	77.23	Inhibition	'='	%	-1.99	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909363	0.0	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		Test	570.61	2	11	10	6	5	155.68	Inhibition	'='	%	0.06	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909375	0.0	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21		Test	411.47	3	9	5	4	3	137.14	Inhibition	'='	%	-3.01	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909378	0.0	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		Test	384.4	2	5	4	5	4	103.12	Inhibition	'='	%	1.75	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909385	0.0	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1		Test	528.63	2	8	11	5	5	106.35	Inhibition	'='	%	1.78	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909390	0.0	[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1	[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		Test	577.08	1	7	8	6	5	86.48	Inhibition	'='	%	2.69	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909391	0.0	[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1	[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		Test	542.64	1	7	8	6	5	86.48	Inhibition	'='	%	-0.22	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909394	0.0	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		Test	623.15	1	8	13	5	5	97.56	Inhibition	'='	%	1.32	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909401	0.0	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		Test	458.47	1	7	6	5	4	104.99	Inhibition	'='	%	0.71	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909404	0.0	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		Test	406.42	3	6	7	4	4	118.43	Inhibition	'='	%	2.64	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909405	0.0	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		Test	458.46	1	5	7	4	4	58.35	Inhibition	'='	%	1.18	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909406	0.0	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		Test	297.36	0	3	2	4	3	30.71	Inhibition	'='	%	2.54	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL202891	0.0	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		Test	328.38	1	4	4	4	4	63.69	Inhibition	'='	%	2.3	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL206544	0.0	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		Test	340.43	1	3	4	4	4	54.46	Inhibition	'='	%	0.82	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL207247	0.0	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		Test	500.96	2	5	7	4	4	76.14	Inhibition	'='	%	-0.71	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL207410	0.0	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		Test	486.93	2	5	6	4	4	76.14	Inhibition	'='	%	1.76	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL220243	0.0	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		Test	283.33	1	4	3	2	2	59.42	Inhibition	'='	%	1.18	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL269450	0.0	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		Test	433.46	1	5	5	5	4	64.86	Inhibition	'='	%	1.91	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL269985	0.0	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		Test	413.48	1	5	6	4	4	77.25	Inhibition	'='	%	-1.24	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL275168	0.0	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		Test	449.92	1	5	5	5	4	64.86	Inhibition	'='	%	3.24	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL275200	0.0	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		Test	471.58	1	5	5	5	4	64.86	Inhibition	'='	%	0.05	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL275724	0.0	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		Test	458.5	2	6	6	5	4	107.95	Inhibition	'='	%	2.22	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL303687	0.0	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		Test	358.41	1	5	5	4	4	77.22	Inhibition	'='	%	4.92	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL362155	0.0	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		Test	490.45	1	7	4	6	5	86.46	Inhibition	'='	%	0.02	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL365297	0.0	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		Test	440.44	1	7	4	6	5	86.46	Inhibition	'='	%	2.55	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL374453	0.0	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		Test	415.28	3	3	3	4	3	86.88	Inhibition	'='	%	0.36	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL379093	0.0	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		Test	429.88	1	4	5	4	4	47.04	Inhibition	'='	%	2.84	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL405021	0.0	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		Test	277.33	2	2	3	4	3	57.78	Inhibition	'='	%	1.02	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL417804	0.0	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		Test	445.5	1	6	6	5	4	74.09	Inhibition	'='	%	0.7	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL428877	0.0	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		Test	443.53	1	5	6	5	4	64.86	Inhibition	'='	%	3.88	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL466412	0.0	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		Test	566.06	2	7	6	5	4	88.61	Inhibition	'='	%	-1.64	CHEMBL1962300	GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL467581	0.0	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		Test	520.57	4	8	9	4	4	141.5	Inhibition	'='	%	1.78	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL471789	0.0	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		Test	476.48	0	5	7	4	4	62.58	Inhibition	'='	%	2.7	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL477978	0.0	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		Test	390.53	2	2	6	4	2	58.2	Inhibition	'='	%	-0.88	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL477979	0.0	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		Test	350.46	2	2	6	3	2	58.2	Inhibition	'='	%	-0.43	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL480371	0.0	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		Test	496.31	1	3	5	4	4	70.14	Inhibition	'='	%	1.28	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL482326	0.0	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		Test	505.52	0	5	7	4	4	65.82	Inhibition	'='	%	-0.36	CHEMBL1962302	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL483747	0.0	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		Test	390.46	1	4	5	4	4	82.28	Inhibition	'='	%	1.77	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL4849874	0.0	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4cc[nH]n4)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4cc[nH]n4)c3)cc2C(F)(F)F)CC1		Test	514.55	3	5	7	4	3	93.36	Inhibition	'='	%	2.5	CHEMBL4816255	Inhibition of human FLT3 at 100 nM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	single protein format
CHEMBL4857910	0.0	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4ccn(C)n4)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4ccn(C)n4)c3)cc2C(F)(F)F)CC1		Test	528.58	2	5	7	4	3	82.5	Inhibition	'='	%	10.5	CHEMBL4816254	Inhibition of human FLT3 at 10 nM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	single protein format
CHEMBL4859074	0.0	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4n[nH]c5ncccc45)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4n[nH]c5ncccc45)c3)cc2C(F)(F)F)CC1		Test	565.6	3	6	7	5	4	106.25	Inhibition	'='	%	17.0	CHEMBL4816255	Inhibition of human FLT3 at 100 nM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	single protein format
CHEMBL4864961	0.0	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cnc5cccnn45)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cnc5cccnn45)c3)cc2C(F)(F)F)CC1		Test	565.6	2	6	7	5	4	94.87	Inhibition	'='	%	11.5	CHEMBL4816254	Inhibition of human FLT3 at 10 nM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	single protein format
CHEMBL4868017	0.0	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4ncc[nH]4)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NC(=O)c4ncc[nH]4)c3)cc2C(F)(F)F)CC1		Test	514.55	3	5	7	4	3	93.36	Inhibition	'='	%	8.0	CHEMBL4816255	Inhibition of human FLT3 at 100 nM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	single protein format
CHEMBL493326	0.0	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		Test	427.91	1	4	6	4	4	79.37	Inhibition	'='	%	2.1	CHEMBL1962301	GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL507329	0.0	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		Test	608.09	2	8	6	6	4	97.84	Inhibition	'='	%	0.76	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL512076	0.0	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		Test	566.06	3	7	7	5	4	97.4	Inhibition	'='	%	2.51	CHEMBL1962099	GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn]	single protein format
